tradingkey.logo
tradingkey.logo
Search

Transmedics Group Inc

TMDX
Add to Watchlist
63.200USD
+1.160+1.87%
Close 05/15, 16:00ETQuotes delayed by 15 min
2.17BMarket Cap
12.52P/E TTM

Transmedics Group Inc

63.200
+1.160+1.87%

More Details of Transmedics Group Inc Company

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Transmedics Group Inc Info

Ticker SymbolTMDX
Company nameTransmedics Group Inc
IPO dateMay 02, 2019
CEOHassanein (Waleed H)
Number of employees728
Security typeOrdinary Share
Fiscal year-endMay 02
Address200 Minuteman Road
CityANDOVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01810
Phone19785520900
Websitehttps://www.transmedics.com/
Ticker SymbolTMDX
IPO dateMay 02, 2019
CEOHassanein (Waleed H)

Company Executives of Transmedics Group Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
185.21K
+4.32%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.18K
+0.41%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
--
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
--
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
3.00K
+88.95%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
2.87K
-41.63%
Dr. Tamer I. Khayal, M.D.
Dr. Tamer I. Khayal, M.D.
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Edward M. Basile
Mr. Edward M. Basile
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
185.21K
+4.32%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.18K
+0.41%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
--
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
OCS Liver net revenue
460.53M
76.58%
OCS Heart net revenue
126.01M
20.95%
OCS Lung net revenue
14.86M
2.47%
By RegionUSD
Name
Revenue
Proportion
United States
584.70M
97.22%
All other countries
16.70M
2.78%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
OCS Liver net revenue
460.53M
76.58%
OCS Heart net revenue
126.01M
20.95%
OCS Lung net revenue
14.86M
2.47%

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.92%
Fidelity Management & Research Company LLC
12.93%
Vanguard Portfolio Management, LLC
5.55%
Vanguard Capital Management, LLC
4.28%
State Street Investment Management (US)
3.69%
Other
59.63%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.92%
Fidelity Management & Research Company LLC
12.93%
Vanguard Portfolio Management, LLC
5.55%
Vanguard Capital Management, LLC
4.28%
State Street Investment Management (US)
3.69%
Other
59.63%
Shareholder Types
Shareholders
Proportion
Investment Advisor
73.74%
Investment Advisor/Hedge Fund
24.06%
Hedge Fund
5.98%
Research Firm
4.71%
Individual Investor
3.29%
Bank and Trust
2.16%
Pension Fund
1.28%
Family Office
0.17%
Sovereign Wealth Fund
0.09%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
865
42.29M
122.36%
-1.74M
2025Q4
802
38.01M
111.22%
-5.64M
2025Q3
762
37.62M
110.09%
-8.17M
2025Q2
746
42.27M
124.01%
-2.30M
2025Q1
751
42.32M
125.08%
-2.32M
2024Q4
728
40.09M
119.11%
-642.74K
2024Q3
673
39.30M
117.10%
+1.37M
2024Q2
615
36.53M
110.85%
-3.27M
2024Q1
544
37.44M
113.97%
-4.28M
2023Q4
512
38.18M
116.94%
-3.46M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
4.81M
14.02%
+72.53K
+1.53%
Dec 31, 2025
Fidelity Management & Research Company LLC
4.47M
13.03%
-128.10K
-2.79%
Dec 31, 2025
State Street Investment Management (US)
1.28M
3.72%
-4.41K
-0.34%
Dec 31, 2025
Nomura Investment Management Business Trust
832.24K
2.43%
-74.03K
-8.17%
Dec 31, 2025
Geode Capital Management, L.L.C.
816.47K
2.38%
+2.90K
+0.36%
Dec 31, 2025
Two Sigma Investments, LP
800.39K
2.33%
-258.30K
-24.40%
Dec 31, 2025
Driehaus Capital Management, LLC
712.04K
2.08%
-26.12K
-3.54%
Dec 31, 2025
Hood River Capital Management LLC
690.36K
2.01%
+11.92K
+1.76%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
4.75%
Clough Select Equity ETF
2.87%
Invesco S&P SmallCap Health Care ETF
2.75%
State Street SPDR S&P Health Care Equipment ETF
2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.47%
iShares S&P Small-Cap 600 Growth ETF
0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.58%
View more
Global X HealthTech ETF
Proportion4.75%
Clough Select Equity ETF
Proportion2.87%
Invesco S&P SmallCap Health Care ETF
Proportion2.75%
State Street SPDR S&P Health Care Equipment ETF
Proportion2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion1.47%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
Proportion0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.58%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI